MyAverix Finance
F · Healthcare
Annexin Pharmaceuticals AB (publ) (Q910)
Biotechnology
Annexin Pharmaceuticals AB (publ) (Q910) is listed on F in the Healthcare sector. Industry: Biotechnology. As of 2026-03-30, reported market cap is $8.19M, P/E ratio is 18.00, net margin is 0.0%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for Q910
Annexin Pharmaceuticals AB (publ) (Q910) — FAQ
What is Annexin Pharmaceuticals AB (publ)'s market cap?
Annexin Pharmaceuticals AB (publ) (Q910) has a reported market cap of $8.19M (data as of 2026-03-30).
What is Q910's P/E ratio?
The price-to-earnings (P/E) ratio for Annexin Pharmaceuticals AB (publ) (Q910) is 18.00 (data as of 2026-03-30).
Does Annexin Pharmaceuticals AB (publ) pay a dividend?
Dividend yield is not available in the current snapshot for Annexin Pharmaceuticals AB (publ) (Q910). Check the MyAverix Finance app for the latest dividend data.
What sector is Annexin Pharmaceuticals AB (publ) in?
Annexin Pharmaceuticals AB (publ) (Q910) is classified in the Healthcare sector (Biotechnology industry).
What exchange is Q910 listed on?
Q910 is listed on F.
What is Annexin Pharmaceuticals AB (publ)'s net margin?
Annexin Pharmaceuticals AB (publ) (Q910) reports a net margin of 0.0% (data as of 2026-03-30).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.